AU9321198A - Dosage forms having improved release properties - Google Patents

Dosage forms having improved release properties

Info

Publication number
AU9321198A
AU9321198A AU93211/98A AU9321198A AU9321198A AU 9321198 A AU9321198 A AU 9321198A AU 93211/98 A AU93211/98 A AU 93211/98A AU 9321198 A AU9321198 A AU 9321198A AU 9321198 A AU9321198 A AU 9321198A
Authority
AU
Australia
Prior art keywords
dosage forms
release properties
improved release
improved
properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU93211/98A
Inventor
Mark R. Herman
Michael Myers
Pradeepkumar P. Sanghvi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biovail Technologies Ltd
Original Assignee
Fuisz Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuisz Technologies Ltd filed Critical Fuisz Technologies Ltd
Publication of AU9321198A publication Critical patent/AU9321198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
AU93211/98A 1997-10-07 1998-09-18 Dosage forms having improved release properties Abandoned AU9321198A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US94606597A 1997-10-07 1997-10-07
US08946065 1997-10-07
US14478498A 1998-09-01 1998-09-01
US09144784 1998-09-01
PCT/US1998/019735 WO1999017743A1 (en) 1997-10-07 1998-09-18 Dosage forms having improved release properties

Publications (1)

Publication Number Publication Date
AU9321198A true AU9321198A (en) 1999-04-27

Family

ID=26842361

Family Applications (1)

Application Number Title Priority Date Filing Date
AU93211/98A Abandoned AU9321198A (en) 1997-10-07 1998-09-18 Dosage forms having improved release properties

Country Status (5)

Country Link
EP (1) EP0969817A1 (en)
JP (1) JP2002528042A (en)
AU (1) AU9321198A (en)
CA (1) CA2273274A1 (en)
WO (1) WO1999017743A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
IE981008A1 (en) * 1998-12-02 2000-06-14 Fuisz Internat Ltd Microparticles Containing Water Insoluble Active Agents
WO2004075913A1 (en) 2003-02-28 2004-09-10 Chugai Seiyaku Kabushiki Kaisha Stabilized preparation containing protein
JP4572296B2 (en) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 Pimobendan oral dosage formulation
JP4572293B2 (en) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 Pimobendan oral dosage formulation
JP4572300B2 (en) * 2006-01-19 2010-11-04 トーアエイヨー株式会社 Pimobendan oral dosage formulation
US11896037B2 (en) * 2016-08-03 2024-02-13 Temple University-Of The Commonwealth System Of Higher Education Microencapsulation of active agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1006990A5 (en) * 1993-04-22 1995-02-07 Univ Gent METHOD AND COMPOSITION TO MAKE AN ACTIVE INGREDIENT IN A solid dosage form.
US5750147A (en) * 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole

Also Published As

Publication number Publication date
CA2273274A1 (en) 1999-04-15
EP0969817A1 (en) 2000-01-12
WO1999017743A1 (en) 1999-04-15
JP2002528042A (en) 2002-08-27

Similar Documents

Publication Publication Date Title
AU2791599A (en) Extended release dosage form
AU8921698A (en) Follistatin-3
AU6598798A (en) Resorcinyl-triazines
AU1027499A (en) 32P-polyphosphazene
AU8495998A (en) Improved dosage units
AU7428698A (en) Analgesic combination
AU5970699A (en) Use
AU1409100A (en) Drugs
AU6827898A (en) Detergent-package combination
AU9066598A (en) Substituted 4-benzoyl-pyrazoles
AU5272198A (en) EMP-charge-eliminator
AU6107698A (en) Release mechanism
AU4117497A (en) Micropolarimeter
AU6998698A (en) Dioxacycloalkan-8-one
AU6185898A (en) Clavaspirins
AU9321198A (en) Dosage forms having improved release properties
AU6220798A (en) Release agent
AU7761998A (en) Korrosionsschutzanstrichstoff
AU6525998A (en) Improved metallo-endopeptidases
AU6117298A (en) Hyponatremia remedies
AU8214598A (en) 3-benzylpiperidine
AU1063699A (en) Release compositions
AU6090898A (en) Substituted 4-benzoyl-pyrazoles
AU5814498A (en) Novel release latch - c-i-p
AU8991998A (en) Renovative pipeliner

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase